Skip to main content
GMAB logo

Genmab A/S

GMABNASDAQHealthcareBiotechnology

$37.00Today:- (-)1Y +14.02%

As of Oct 16, 2026 close

Market cap
$23.34B
P/E (TTM)
29.61
Forward P/E
36.72
Dividend yield
-
52-week range
$23.62$40.17
Volume (live)
-
Avg. volume (3M)
3.41M

Genmab A/S (GMAB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Genmab A/S stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(17 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$109.22
+195.19% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest GMAB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Gregory Renza
Truist
BuyMaintains
$40.00 → $45.00
Charlie Haywood
BofA Securities
BuyMaintains
$375.73 → $428.34
Ram Selvaraju
HC Wainwright
BuyReiterates
$40.00 → $50.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Michael Schmidt
Guggenheim
BuyMaintains
$45.00 → $54.00
Matt Phipps
William Blair
BuyReiterates
-
Gregory Renza
Truist
BuyMaintains
-
Yaron Werber
TD Cowen
BuyReiterates
$43.00
Charlie Haywood
BofA Securities
BuyMaintains
$303.29 → $379.11
Michael Schmidt
Guggenheim
BuyMaintains
$45.00 → $54.00
Ram Selvaraju
HC Wainwright
BuyReiterates
$40.00
Benjamin Jackson CFA
Jefferies
BuyMaintains
-
Rajan Sharma
Goldman Sachs
BuyMaintains
$2400.00
James Gordon CFA
Barclays
BuyMaintains
-
Charlie Haywood
BofA Securities
BuyMaintains
-
Judah Frommer
Morgan Stanley
HoldMaintains
$33.00 → $35.00
Michael Schmidt
Guggenheim
BuyMaintains
$40.00 → $42.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for GMAB?

The analyst consensus rating for GMAB is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for GMAB?

The average 12-month price target for GMAB is $109.22, representing an upside of 195.2% from the Oct 16, 2026 close of $37.00.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.